Market Cap 50.36M
Revenue (ttm) 0.00
Net Income (ttm) -23.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 546,200
Avg Vol 721,842
Day's Range N/A - N/A
Shares Out 37.03M
Stochastic %K 56%
Beta 0.00
Analysts Sell
Price Target $14.00

Company Profile

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Industry: Biotechnology
Sector: Healthcare
Phone: 312 416 8592
Address:
444 West Lake Street, Suite 1700, Chicago, United States
JohnTrack
JohnTrack Dec. 24 at 5:15 PM
$MAIA monitoring flush and recover!
0 · Reply
JohnTrack
JohnTrack Dec. 24 at 3:23 PM
$MAIA Board Members have participated in the last offering https://www.rapidticker.com/news/maia-maia-biotechnology-board-members-continue-cae8a3
0 · Reply
MGeronimo
MGeronimo Dec. 23 at 9:46 PM
$MAIA 200K insider buy
1 · Reply
KhokPiSDP
KhokPiSDP Dec. 23 at 6:28 PM
0 · Reply
LabPsycho
LabPsycho Dec. 23 at 5:05 PM
$MAIA Gee...what a surprise, yet another offering after yet another bunch of (laughable sized) insider buying (the pump primer), + the vacuous pumper articles. Top it off with a buy recommendation by an 'investment' firm with the name Nobel in it to really make it see legit and authoritative. I'd like to be in on this gig economy where I spend $10-20K of my money to have an income of 10X paid for by the believers.
1 · Reply
Gozer_
Gozer_ Dec. 23 at 2:45 PM
$MAIA 👀
0 · Reply
MoneyHelix
MoneyHelix Dec. 23 at 2:42 PM
$MAIA There is a very good chance that a deal is being made as we speak. LOAD UP!! 🔥📈🚀💰🤑
0 · Reply
vividC
vividC Dec. 23 at 2:40 PM
$MAIA my sense they keep raising small amounts because they are close to a financial agreement.
1 · Reply
AZOZ
AZOZ Dec. 23 at 2:20 PM
$MAIA $PLX Insider's love it right now!
0 · Reply
Tfizzle
Tfizzle Dec. 23 at 2:13 PM
$MAIA https://finviz.com/quote.ashx?t=MAIA insiders loaded
0 · Reply
Latest News on MAIA
MAIA Biotechnology Announces $1.51 Million Private Placement

Dec 16, 2025, 4:15 PM EST - 8 days ago

MAIA Biotechnology Announces $1.51 Million Private Placement


MAIA Biotechnology Announces $736,600 Private Placement

Oct 13, 2025, 4:20 PM EDT - 2 months ago

MAIA Biotechnology Announces $736,600 Private Placement


MAIA Biotechnology Announces $2.25 Million Private Placement

Sep 29, 2025, 4:30 PM EDT - 3 months ago

MAIA Biotechnology Announces $2.25 Million Private Placement


MAIA Biotechnology Announces $1.08 Million Private Placement

May 5, 2025, 4:05 PM EDT - 8 months ago

MAIA Biotechnology Announces $1.08 Million Private Placement


MAIA Biotechnology Announces Private Placement of $2,715,000

Feb 18, 2025, 3:44 PM EST - 11 months ago

MAIA Biotechnology Announces Private Placement of $2,715,000


MAIA Biotechnology to Present at Biotech Showcase 2025

Jan 10, 2025, 9:45 AM EST - 1 year ago

MAIA Biotechnology to Present at Biotech Showcase 2025


MAIA Biotechnology Announces $2.44 Million Private Placement

Oct 28, 2024, 7:00 PM EDT - 1 year ago

MAIA Biotechnology Announces $2.44 Million Private Placement


JohnTrack
JohnTrack Dec. 24 at 5:15 PM
$MAIA monitoring flush and recover!
0 · Reply
JohnTrack
JohnTrack Dec. 24 at 3:23 PM
$MAIA Board Members have participated in the last offering https://www.rapidticker.com/news/maia-maia-biotechnology-board-members-continue-cae8a3
0 · Reply
MGeronimo
MGeronimo Dec. 23 at 9:46 PM
$MAIA 200K insider buy
1 · Reply
KhokPiSDP
KhokPiSDP Dec. 23 at 6:28 PM
0 · Reply
LabPsycho
LabPsycho Dec. 23 at 5:05 PM
$MAIA Gee...what a surprise, yet another offering after yet another bunch of (laughable sized) insider buying (the pump primer), + the vacuous pumper articles. Top it off with a buy recommendation by an 'investment' firm with the name Nobel in it to really make it see legit and authoritative. I'd like to be in on this gig economy where I spend $10-20K of my money to have an income of 10X paid for by the believers.
1 · Reply
Gozer_
Gozer_ Dec. 23 at 2:45 PM
$MAIA 👀
0 · Reply
MoneyHelix
MoneyHelix Dec. 23 at 2:42 PM
$MAIA There is a very good chance that a deal is being made as we speak. LOAD UP!! 🔥📈🚀💰🤑
0 · Reply
vividC
vividC Dec. 23 at 2:40 PM
$MAIA my sense they keep raising small amounts because they are close to a financial agreement.
1 · Reply
AZOZ
AZOZ Dec. 23 at 2:20 PM
$MAIA $PLX Insider's love it right now!
0 · Reply
Tfizzle
Tfizzle Dec. 23 at 2:13 PM
$MAIA https://finviz.com/quote.ashx?t=MAIA insiders loaded
0 · Reply
Tfizzle
Tfizzle Dec. 23 at 1:44 PM
0 · Reply
GISBlaster98
GISBlaster98 Dec. 23 at 1:38 PM
$MAIA Nice! More insider buying!
0 · Reply
Mindscan
Mindscan Dec. 23 at 1:02 AM
$MAIA Nice start of the week💪💪💪
0 · Reply
Chartwatcher1
Chartwatcher1 Dec. 22 at 8:38 PM
$VSEE looking frisky ...at .46 $MAIA dried out, flat looking for bids....im already loaded $NAK, pop up in the am, with high vol, right up to the top of Wainright price target, been pulling back since ,hmmm mot yet $IOBT, lets try it again , back in at .70
0 · Reply
Chemaster
Chemaster Dec. 22 at 4:40 PM
$MAIA Some people rely on coin flips with a 50% chance of winning. The average biotech startup has only about a 5% chance of success. Yet Maia Biotechnology is already in Phase 3 rapid enrollment trials, with estimated odds of success around 60% and a potential 10x–50x upside. Those are odds I much prefer.
1 · Reply
Tfizzle
Tfizzle Dec. 19 at 1:51 PM
0 · Reply
Rschaffnerjr
Rschaffnerjr Dec. 18 at 6:55 PM
$MAIA Dec. 17, 2025 MAIA Biotechnology, Inc. (MAIA) Gets a Buy from Noble Financial MAIA Biotechnology, Inc. (MAIA) Gets a Buy from Noble Financial Noble Financial analyst Robert LeBoye reiterated a Buy rating on MAIA Biotechnology, Inc. yesterday and set a price target of $14.00.
0 · Reply
Mindscan
Mindscan Dec. 17 at 5:57 PM
$MAIA 4 red days in a row, we will start reversing, I go long anyways, just park and forget for a while 😴
0 · Reply
MartinMercados
MartinMercados Dec. 17 at 2:01 PM
$MAIA pullbacks after catalysts are normal. COULD RETURN TO $1.75 Following the recent rally driven by news of Phase III trials, $MAIA is now in a healthy pullback, likely digesting gains and the $1.51 million private placement. 📉 Technical outlook • Rejection near the $1.75 highs. • Pullback to the 0.61 Fibonacci zone ($1.20). • Price is currently holding at $1.20-$1.23 support. • As long as it remains at $1.10-$1.15, the structure remains constructive and may see further momentum. 🧠 Fundamental context • Phase 3 trial underway (important long-term catalyst).
1 · Reply
Zezo88
Zezo88 Dec. 17 at 1:10 PM
0 · Reply
JohnTrack
JohnTrack Dec. 16 at 11:00 PM
$MAIA hovering this chart, chill!
0 · Reply
MoneyHelix
MoneyHelix Dec. 16 at 10:00 PM
$MAIA $14 price target Fast Track Designation Outperform Rating Insiders buying on the open market and haven't sold a single share since company formation. Phase 3 asset targeting a Hallmark of Cancer 3x ODDs 1x Breakthrough Therapy Designation Science verified by Regeneron, Roche, BeOne, and NIH with Clinical Supply Agreements in place. Increasing M&A and Deal-making activity in biotech industry. LOAD UP! 📈💰🤑💰📈
2 · Reply